Nilandron

Nilandron is a brand name of nilutamide, approved by the FDA in the following formulation(s):

NILANDRON (nilutamide - tablet; oral)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: April 30, 1999
  
  Strength(s): 150MG ^[RLD]

Has a generic version of Nilandron been approved?

No. There is currently no therapeutically equivalent version of Nilandron available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nilandron. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Nilandron.

See also...

• Nilandron Consumer Information (Wolters Kluwer)
• Nilandron Consumer Information (Cerner Multum)
• Nilandron Advanced Consumer Information (Micromedex)
• Nilandron AHFS DI Monographs (ASHP)
• Nilutamide Consumer Information (Wolters Kluwer)
• Nilutamide Consumer Information (Cerner Multum)
• Nilutamide Advanced Consumer Information (Micromedex)
• Nilutamide AHFS DI Monographs (ASHP)